Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA-1975 and mRNA-1982 Vaccines Against Lyme Disease in Healthy Adults
NCT05975099Phase 2Completed
- Sponsor
- Moderna Inc
- Start
- Jul 2023
- Primary completion
- May 2025
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mRNA-1975 and mRNA-1982 in Lyme disease (8 arms), sponsored by Moderna Inc. Primary endpoints: Number of Participants With Solicited Local and Systemic Adverse Reactions, Number of Participants With Unsolicited Adverse Events and 1 more. Started Jul 2023; status: completed.
02
Drugs
mRNA-1975mRNA-1982
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT05975099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05975099.